ShiraTronics

Brooklyn Park, US · Founded 2018 · Delaware corporation · 8 known investors

ShiraTronics is a medical device company developing an implantable device to treat chronic migraine disease. It is a privately held company operating in the medical device and healthcare industry.

BiotechHardwareHealthtechMedical Devicesin /shiratronics-inc

Founders & leadership

Robert BinneyExecutive Officer, Director

Joyce EronyDirector

Zack ScottDirector

Brad ValeDirector

Casey TanseyDirector

Mudit JainExecutive Officer, Director

Philip H. OettingerExecutive Officer

Investors · 8

Amzak HealthNew York

APERTURE Venture PartnersBoston · $1M – $5M

Breakout VenturesSan Francisco · $500K – $6M

Global BioAccess FundNew York · $10M

OSF VenturesPeoria

Seroba Life SciencesDublin · $540K – $7.6M

Treo Ventures, LlcMinneapolisvia Brad H. Vale · board

US Venture PartnersMenlo Park · $500K – $10M

Reported raises · per SEC filings

Form D private placements

▶$37.4MraisedSep 2024 · 30 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Philip H. OettingerExecutive Officer
Robert BinneyExecutive Officer, Director
Joyce EronyDirector
Zack ScottDirector
Brad ValeDirector
Casey TanseyDirector
Mudit JainExecutive Officer, Director

Offering amount: $66M
Amount sold: $37.4M
Minimum investment: $1
First sale: Sep 2024
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$41.7MraisedAug 2023 · 11 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Philip OettingerExecutive Officer
Joyce EronyDirector
Casey TanseyDirector
Mudit JainDirector
Robert BinneyExecutive Officer, Director
Brad ValeDirector

Offering amount: $42.1M
Amount sold: $41.7M
Minimum investment: $1
First sale: Oct 2019
Incorporated: Corporation, Delaware, 2018
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.